user

Receptor Tyrosine Kinase Kinase-like Orphan Receptor 1 (ROR1) as a Selective Molecular Target in Androgen-Dependent and Androgen-Independent Prostate Cancer

被引：0
|
作者：
Sivaganesh, Vignesh
Promi, Nazifa
Maher, Salma
Peethambaran, Bela
机构：
来源：
FASEB JOURNAL | 2021年 / 35卷
关键词：
D O I：
10.1096/fasebj.2021.35.S1.02938
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Discovery of Novel Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) Inhibitors for Cancer Treatment
    Luo, Dongdong
    Qiu, Xingyang
    Zheng, Qingquan
    Ming, Yue
    Pu, Wencheng
    Ai, Ming
    He, Jianhua
    Peng, Yong
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024,
  • [2] Meta-Analysis of Survival Effects of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Jeong, Soo Young
    Lee, Kyung-jun
    Cha, Jieum
    Park, So Yoon
    Kim, Hyeong Su
    Kim, Jung Han
    Lee, Jae-Jun
    Kim, Namhyeok
    Park, Sung Taek
    [J]. MEDICINA-LITHUANIA, 2022, 58 (12):
  • [3] Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy
    Shabani, Mahdi
    Naseri, Jila
    Shokri, Fazel
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2015, 19 (07) : 941 - 955
  • [4] Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL)
    Uhrmacher, Sabrina
    Schmidt, Christina
    Erdfelder, Felix
    Poll-Wolbeck, Simon Jonas
    Gehrke, Iris
    Hallek, Michael
    Kreuzer, Karl-Anton
    [J]. LEUKEMIA RESEARCH, 2011, 35 (10) : 1360 - 1366
  • [5] Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) - a Putative Diagnostic Marker for Chronic Lymphocytic Leukemia (CLL).
    Uhrmacher, Sabrina
    Hertweck, Magdalena
    Paesler, Julian
    Erdfelder, Felix
    Filipovich, Alexandra
    Poll-Wolbeck, Simon Jonas
    Razavi, Regina
    Gandhirajan, Rajesh Kumar
    Gehrke, Iris
    Hallek, Michael
    Kreuzer, Karl Anton
    [J]. BLOOD, 2009, 114 (22) : 635 - 635
  • [6] Receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a potential target antigen for immunotherapy of human B cell chronic lymphocytic leukemia
    Baskar, Sivasubramanian
    Kwong, Ka Yin
    Hofer, Thomas
    Levy, Jessica M.
    Kennedy, Michael G.
    Wilson, Wyndham H.
    Wiestner, Adrian
    Rader, Christoph
    [J]. JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 671 - 672
  • [7] Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)
    Qiao, Jennifer X.
    Witmer, Mark R.
    Lee, Ving
    Wang, Tammy C.
    Reid, Patrick C.
    Arioka, Yuki
    Farr, Glen
    Hill-Drzewi, Melissa
    Schweizer, Liang
    Yamniuk, Aaron
    Cheng, Lin
    Abramczyk, Bozena
    Corbett, Martin
    Calambur, Deepa
    Szapiel, Nicolas
    Ryseck, Rolf
    Ponath, Paul
    Poss, Michael A.
    Carter, Percy
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 98
  • [8] Development of Cirmtuzumab Antibody-Drug Conjugates (ADCs) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1)
    Mian, Yousaf A.
    Widhopf, George F., II
    Thanh-Trang Vo
    Jessen, Katti
    Rassenti, Laura Z.
    Kipps, Thomas J.
    [J]. BLOOD, 2018, 132
  • [9] Metformin represses androgen-dependent and androgen-independent prostate cancers by targeting androgen receptor
    Wang, Yan
    Liu, Gaolei
    Tong, Dali
    Parmar, Henna
    Hasenmayer, Donald
    Yuan, Wenqiang
    Zhang, Dianzheng
    Jiang, Jun
    [J]. PROSTATE, 2015, 75 (11): : 1187 - 1196
  • [10] Androgen receptor as a target in androgen-independent prostate cancer - Discussion
    Sartor, O
    Balk, SP
    Brown, M
    [J]. UROLOGY, 2002, 60 (3A) : 138 - 139
12345